Faculty

Institution

Unit

Venue

Julia Maxson

Associate Professor

Oregon Health & Science University

Affiliations

Biostatistics Shared Resources

Institute Of Knight Cancer

OHSU School of Medicine

Cancer Early Detection Advanced Research Center (Cedar)

Department Of Cell, Developmental And Cancer Biology

Department Of Medicine

Department Of Otolaryngology - Head And Neck Surgery

Department Of Pediatrics

Division Of Oncological Sciences

Center For Experimental Therapeutics

Center Of Cancer Early Detection Advanced Research (Cedar)

Institute Of Knight Cancer

Center Of Knight Cancer

Department of Medicine

Division Of Hematology/Medical Oncology

Division of Hematology & Medical Oncology

Flow Cytometry Shared Resource

Institute Of Knight Cancer

Department Of Medicine

Hematology and Medical Oncology

Department Of Pediatrics

Hematology and Oncology

Cancer Early Detection Advanced Research Center (Cedar)

Institute Of Knight Cancer

Division Of Oncological Sciences

Institute Of Knight Cancer

Department Of Cell, Developmental And Cancer Biology

Institute Of Knight Cancer

Division Of Hematology/Medical Oncology

Institute Of Knight Cancer Insitute

Institute Of University Knight Cancer

Department Of Otolaryngology - Head And Neck Surgery

Molecular Biology of Head and Neck Cancer

OHSU Knight Cancer Institute

Oregon Health & Science University

Julia Maxson is currently serving as a Biostatistics Shared Resources Associate Professor at Oregon Health & Science University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Julia Maxson

Oregon Health & Science University

Associate Professor

You can click a keyword to filter the displayed items

cell biology leukemia oncogenes hematological malignancies hematology molecular biology myeloid neoplasia tumor biology cancer research molecular cancer cancer genetics cell signaling molecular cell biology cancer cells oncology pathology immunology molecular medicine medicinal research cancer genomics molecular diagnostics cancer biology chronic neutrophilic leukemia receptors oncogenic agent acute myeloid leukemia signal transduction cellular therapy cell research enzyme inhibition mixed-phenotype acute leukemia signaling pathways novel therapies biological chemistry cellular physiology experimental medicine therapeutic efficacy receptor (biochemistry) cellular biochemistry cytogenetics medical genetics disease progression heme homeostasis cell trafficking intracellular trafficking glucocorticoids skeletal muscle molecular pathways granulocyte atypical cml hepcidin expression cebpa mutations pediatric aml cancer discovery mammalian biology mutagenesis malignant blood disorders malignant disease lymphoid neoplasia genetic basis anticoagulants g protein-coupled receptor heme degradation biochemical genetics heme signaling immunologic mechanisms drug response integrative analysis specific mutation lethal neutrophilic neoplasia therapeutic jak inhibition genomic landscape ambiguous diagnosis neutrophilic leukemias significant clinical response jak1/2 inhibition molecular and cellular biology gynecologic oncology functional genomics developmental biology carcinogenesis therapeutic targets human genetics bioinformatics genetics mutagenesis (molecular biology technique) cancer immunotherapy epigenetics lung cancer jama oncology omics dna repair gene expression radiation oncology biomedical informatics plo biology nucleic acids molecular informatics systems biology ovarian cancer cancer letter cancer care tumor microenvironment genome biology biostatistics metastasis brain tumor research chromatin clinical proteomics

Notable Scholarly Works

Notable Federal Grants

Collaborators

Myst Acetyltransferases Interact With Setbp1 and Are a Targetable Therapeutic Vulnerability in Setbp1-Mutant Leukemia. Blood Cancer Discovery (2026)

leukemiacancer geneticsmyeloid neoplasiacell regulationcell signalingmolecular cancersetbp1-mutant leukemiatranscription factorsmolecular cell biologytargetable therapeutic vulnerabilitymolecular biologyoncogenic agentoncogenescancer cellschromatintumor biologycell biology

Pu.1 Inhibition Sensitizes Stem-Monocytic Aml to Bcl2 Blockade. bioRxiv (Cold Spring Harbor Laboratory) (2026)

cell deathleukemiamyeloid neoplasiacell signalingtherapeutic targetstherapeutic efficacypu.1 inhibitioncellular therapyexperimental medicinemolecular medicinecell biology

CORRECTION: Citeviz: Interactively Classify Cell Populations in Cite-Seq via a Flow Cytometry-Like Gating Workflow Using R-Shiny. BMC Bioinformatics (2025)

genomicsgenome biologystatistical softwareflow cytometry-likesystems biologybiologycell researchomics datasetsscientific datacell populationsscientific data managementcomputational biologybioinformatics

Dual Asxl1 and Csf3R Mutations Drive Myeloid-Biased Stem Cell Expansion and Enhance Neutrophil Differentiation. Blood Advances (2025)

hematological malignanciesmyeloid neoplasiacell researchmixed-phenotype acute leukemiastem cell mobilizationcell biologystem cell researchhematologystem cellsenhance neutrophil differentiationcellular differentiationleukemiadevelopmental biologytumor biologyimmunologyoncogenescell transplantationcellular therapymolecular medicine

Supplementary Fig. 11 From Disruption of the Myc Superenhancer Complex by Dual Targeting of Flt3 and Lsd1 in Acute Myeloid Leukemia. (2025)

hematological malignanciesleukemiamyeloid neoplasiacancer researchcell signalingmolecular cancertherapeutic targetsmolecular cell biologysupplementary figdrug discoverymolecular biologyoncogenic agentoncogenescancer cellsacute myeloid leukemiatumor biologymyc superenhancer complexcell biology

Drug-Induced and Malignancy-Associated Neutrophilic Dermatoses in Patients With Hematologic Malignancies: A Single Institution Experience. Dermatology (2024)

dermatologymedicineleukemiaclinical dermatologydermatological treatmenthematologyskin pharmacologyhematologic malignanciesdermatopathologymalignancy-associated neutrophilic dermatosesoncologysingle institution experiencepathology

Setbp1 Regulates Myst Acetyltransferase Complexes to Drive a Leukemogenic Gene Expression Program. Blood (2024)

carcinogenesisgene expressioncell deathleukemiamolecular cell biologygene functionmolecular biologyoncogenescancer cellstumor biologygene regulationcell biology

3047 – Role of Epigenetic Dysfunction in Chronic Neutrophilic Leukemia. Experimental Hematology (2023)

immunologyleukemiaepigenomicshematologycancer researchepigenetic changesmolecular cell biologyepigeneticspathologychromatincell biology

Abstract 3489: Tnk1 is a Ubiquitin Sensing Kinase That Can Be Targeted in Vivo to Block Tumor Growth. Cancer Research (2023)

Tania Lopez-PalaciosTsz-Yin ChanChristina M. EgbertSpencer AshworthAlec VaughanTanya V. ForostyanAdam SiddiquiJason M. FoulksJames MoodyJulia E. MaxsonJeffrey W. TynerSteven L. WarnerJoshua Lyon Andersen

cell signalingcell biologytumor targetingcancer caremolecular cancercancer biologyubiquitin sensing kinaseleukemiacancer researchcancer immunotherapycancer growthdrug targetingcancer treatmenttumor biologytumor growthenzyme inhibitionpharmacologymolecular biologyoncologymedicinal research

Data From a Novel Germline Variant in Csf3R Reduces N-Glycosylation and Exerts Potent Oncogenic Effects in Leukemia. (2023)

David R. SpiciarichStephen T. OhAmy FoleySeamus B. HughesMichael J. MauroOmar Abdel-WahabRichard D. PressRosa VinerSarah L. ThompsonQiushi ChenParastoo AzadiCarolyn R. BertozziJulia E. Maxson

hematological malignanciescarcinogenesisleukemiapharmacologycancer geneticscancer researchmolecular cancergeneticscancer genomicscancer immunotherapymolecular biologyoncogenic agentmedicinal researchnovel germline variantcancer biologytumor biologymolecular medicine

1
2
3
4
5
9
10 / page

Julia Maxson

Associate Professor

Oregon Health & Science University

Affiliations

Biostatistics Shared Resources

Institute Of Knight Cancer

OHSU School of Medicine

Cancer Early Detection Advanced Research Center (Cedar)

Department Of Cell, Developmental And Cancer Biology

Department Of Medicine

Department Of Otolaryngology - Head And Neck Surgery

Department Of Pediatrics

Division Of Oncological Sciences

Center For Experimental Therapeutics

Center Of Cancer Early Detection Advanced Research (Cedar)

Institute Of Knight Cancer

Center Of Knight Cancer

Department of Medicine

Division Of Hematology/Medical Oncology

Division of Hematology & Medical Oncology

Flow Cytometry Shared Resource

Institute Of Knight Cancer

Department Of Medicine

Hematology and Medical Oncology

Department Of Pediatrics

Hematology and Oncology

Cancer Early Detection Advanced Research Center (Cedar)

Institute Of Knight Cancer

Division Of Oncological Sciences

Institute Of Knight Cancer

Department Of Cell, Developmental And Cancer Biology

Institute Of Knight Cancer

Division Of Hematology/Medical Oncology

Institute Of Knight Cancer Insitute

Institute Of University Knight Cancer

Department Of Otolaryngology - Head And Neck Surgery

Molecular Biology of Head and Neck Cancer

OHSU Knight Cancer Institute

Oregon Health & Science University

Julia Maxson is currently serving as a Biostatistics Shared Resources Associate Professor at Oregon Health & Science University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Julia Maxson

Oregon Health & Science University

Associate Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Myst Acetyltransferases Interact With Setbp1 and Are a Targetable Therapeutic Vulnerability in Setbp1-Mutant Leukemia. Blood Cancer Discovery (2026)

Pu.1 Inhibition Sensitizes Stem-Monocytic Aml to Bcl2 Blockade. bioRxiv (Cold Spring Harbor Laboratory) (2026)

cell deathleukemiamyeloid neoplasiacell signalingtherapeutic targetstherapeutic efficacypu.1 inhibitioncellular therapyexperimental medicinemolecular medicinecell biology

CORRECTION: Citeviz: Interactively Classify Cell Populations in Cite-Seq via a Flow Cytometry-Like Gating Workflow Using R-Shiny. BMC Bioinformatics (2025)

Dual Asxl1 and Csf3R Mutations Drive Myeloid-Biased Stem Cell Expansion and Enhance Neutrophil Differentiation. Blood Advances (2025)

Supplementary Fig. 11 From Disruption of the Myc Superenhancer Complex by Dual Targeting of Flt3 and Lsd1 in Acute Myeloid Leukemia. (2025)

Drug-Induced and Malignancy-Associated Neutrophilic Dermatoses in Patients With Hematologic Malignancies: A Single Institution Experience. Dermatology (2024)

Setbp1 Regulates Myst Acetyltransferase Complexes to Drive a Leukemogenic Gene Expression Program. Blood (2024)

carcinogenesisgene expressioncell deathleukemiamolecular cell biologygene functionmolecular biologyoncogenescancer cellstumor biologygene regulationcell biology

3047 – Role of Epigenetic Dysfunction in Chronic Neutrophilic Leukemia. Experimental Hematology (2023)

immunologyleukemiaepigenomicshematologycancer researchepigenetic changesmolecular cell biologyepigeneticspathologychromatincell biology

Abstract 3489: Tnk1 is a Ubiquitin Sensing Kinase That Can Be Targeted in Vivo to Block Tumor Growth. Cancer Research (2023)

Data From a Novel Germline Variant in Csf3R Reduces N-Glycosylation and Exerts Potent Oncogenic Effects in Leukemia. (2023)

David R. SpiciarichStephen T. OhAmy FoleySeamus B. HughesMichael J. MauroOmar Abdel-WahabRichard D. PressRosa VinerSarah L. ThompsonQiushi ChenParastoo AzadiCarolyn R. BertozziJulia E. Maxson

1
2
3
4
5
9
10 / page